– published in Frontiers in Pharmacology
Summary
Curcumin: The Epigenetic Cancer Fighter. This review spotlights curcumin, the active compound in turmeric, moving beyond its basic biochemistry to its advanced therapeutic potential. It emphasizes curcumin’s crucial role as an epigenetic modulator, detailing how it combats cancer by regulating gene expression without altering the underlying DNA sequence. The article explores sophisticated drug delivery systems (e.g., nanoparticles) needed to overcome curcumin’s poor bioavailability. This research underscores curcumin’s innovation as a safe, natural agent for future cancer management strategies.